Exelixis (EXEL)
$69.39 +4.82% Close Oct 30, 2026 Live
Exelixis stock today
Exelixis closed at $69.39 on October 30, 2026, up 4.82% on the day. Over the past year it returned +78.2% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $17.2 billion.
$40.00$50.00$60.00$70.00
NovJan 2026MarMayJulSep
| Period | EXEL | S&P 500 (SPY) |
|---|---|---|
| 1 month | +18.8% | -0.9% |
| 3 months | +24.0% | +2.1% |
| Year to date | +58.3% | +11.7% |
| 1 year | +78.2% | +12.4% |
| 3 years | +242.8% | +88.5% |
| 5 years | +222.6% | +76.0% |
Key statistics
- Market value
- $17.2B
- P/E (trailing)
- 20.7
- Forward P/E
- 16.8
- Price / sales
- 6.9
- 52-week range
- $37.90 to $69.39
About Exelixis
Exelixis develops and commercializes oncology drugs for cancer treatment.
Sector: Health Care · Industry: Biotechnology
More on Exelixis
- Financials: revenue, earnings and segmentsRevenue +7% in the year to Jan 2026
- Valuation: P/E history and peersP/E 20.7, median 22.3 at its last 8 year ends
- Returns: what $1,000 became$1,000 ten years ago is $6,378 today
No forecast, no recommendation. This page describes Exelixis from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.